IGT to Host Webinar on CMS Proposed Rule on Value-based Purchasing

On Monday, July 13, 2020 at 4 PM Eastern Time, the Institute for Gene Therapies (IGT) will host a conversation with recognized experts who will share perspectives on the CMS proposed rule that makes changes to the Medicaid Drug Rebate Program (MDRP) to facilitate value-based purchasing (VBP) arrangements.


Former Congressman and IGT Chairman Erik Paulsen will moderate the discussion to shed light on the proposed rule and its implications for patients, payers and manufacturers, particularly as it relates to transformative gene therapies. Speakers include:


Stuart Portman | Health Policy Advisor, U.S. Senate Finance Committee

Annie Kennedy | Chief of Policy and Advocacy, EveryLife Foundation

Mark Trusheim, MSc | Strategic Director, MIT NEWDIGS

Thomas Evegan | Vice President of Integrichain

Lauren Randall Buckley | Director of Health Policy & Advocacy of IGT



For more information, and to register for this event, click here.

high res logo.png

The Institute for Gene Therapies advocates for a modernized regulatory and reimbursement framework that encourages the development of transformative gene therapies and promotes patient access. 

Get In Touch

IGT. © 2020 All Rights Reserved